Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $111.24M.
ENTERPRISE VALUE (EV)
$111.24M
Genelux Corporation
Market Cap
$116.57M
Enterprise Value (EV)
$111.24M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Genelux Corporation (GNLX) | $116.57M | $111.24M |
| Coya Therapeutics, Inc. (COYA)vs › | $116.35M | N/A |
| BGM Group Ltd. (BGM)vs › | $116.34M | $106.00M |
| Foghorn Therapeutics Inc. (FHTX)vs › | $116.84M | $91.86M |
| Lucid Diagnostics Inc. (LUCD)vs › | $116.20M | $107.70M |
| Insight Molecular Diagnostics Inc. (IMDX)vs › | $117.21M | $102.08M |
| Caribou Biosciences, Inc. (CRBU)vs › | $117.53M | $117.99M |
| MaxCyte, Inc. (MXCT)vs › | $114.08M | $116.29M |
| LENZ Therapeutics, Inc. (LENZ)vs › | $119.38M | $95.30M |
| TuHURA Biosciences, Inc. (HURA)vs › | $121.63M | $121.04M |
Market Cap
$116.57M
Total Debt
$0.00
Cash
$5.33M
Enterprise Value
$111.24M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
